Asia-Pacific Blood Glucose Monitoring Market Size- By Self Monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Asia-Pacific Blood Glucose Monitoring Market Size- By Self Monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Asia-Pacific Blood Glucose Monitoring Market Introduction and Overview

According to SPER market research, ‘Asia Pacific Blood Glucose Monitoring Market Size – By Self-monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the APAC Blood Glucose Monitoring Market is predicted to reach USD 7.53 billion by 2033 with a CAGR of 7.98%.

Blood glucose monitoring devices are used by diabetics to measure and manage their blood glucose levels. These technologies allow patients to check their blood glucose levels quickly and non-invasively. The devices do a quantitative test to determine blood glucose levels. People can control their condition by monitoring blood glucose levels and seeking medical attention when necessary.

The COVID-19 epidemic contributes to the growth of the Asia-Pacific Diabetes Care Devices Market. People with diabetes who test positive for COVID-19 may experience unusual fluctuations in blood sugar, elevated blood sugar, and other diabetes-related problems. The severity and mortality of COVID-19 were significantly higher in people with diabetes, especially in those with poor glycemic control and type 1 (T1DM) or type 2 (T2DM) diabetes mellitus.

Scope of the Report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Self-monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User
Regions covered China, Japan, Australia, India, Rest of Asia Pacific

Companies Covered

Abbott Diabetes Care, Acon, Agamatrix Inc., Arkray, Ascensia Diabetes Care, Bionime Corporation, Dexcom, Johnson and Johnson (Lifescan), Medisana, Medtronic, Roche, Rossmax, Others

Asia Pacific Blood Glucose Monitoring Market Segmentation

By Self-monitoring Blood Glucose Devices:Based on the Self-monitoring Blood Glucose Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Glucometer Devices, Test Strips, Lancets.

By Continuous Glucose Monitoring Devices:Based on the Continuous Glucose Monitoring Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Sensors, Durables.

By End User:Based on the End User, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Hospital/Clinics, Home/Personal.